2 Undervalued AI Stocks to Buy Before They Soar 112% and 196%, According to Certain Wall Street Analysts
Feb 18, 2026 by Harsh Chauhan2 Top Artificial Intelligence Stocks to Buy in FebruaryThese companies are growing at healthy rates and are on track to capitalize on AI's growth in their respective industries.
Feb 18, 2026 by Reuben Gregg BrewerIs Brighthouse Financial an Underrated Financial Stock Investment Play?Brighthouse Financial sells life insurance, but that's not the big story driving the stock right now.
Feb 18, 2026 by Daniel Sparks1 Reason Why Tesla Stock May Keep UnderperformingThe growth stock has struggled this year despite positive updates from CEO Elon Musk.
Feb 18, 2026 by Catie Hogan2 Utility Stocks to Buy in FebruaryNextEra Energy and Southern Company are producing strong growth numbers and increasing dividends.
Feb 18, 2026 by Christy BieberWhat Does the Average Retiree Really Get From Social Security?Understanding how much your Social Security checks will be is important because your benefits may not be as much as you think.
Feb 18, 2026 by Harsh Chauhan2 Top Artificial Intelligence Stocks to Buy in FebruaryThese companies are growing at healthy rates and are on track to capitalize on AI's growth in their respective industries.
Feb 18, 2026 by Eric VolkmanWhy HF Sinclair Stock Swooned on WednesdayIt was very much a good news/bad news kind of day for the energy company.
Feb 18, 2026 by Will EbiefungWhere Will Micron Stock Be in 5 Years?This tech giant has an interesting future.
Feb 18, 2026 by Eric VolkmanWhy Applovin Stock Popped TodayOpportunity continues to abound for the company's solutions.
Feb 18, 2026 by Reuben Gregg BrewerIs Brighthouse Financial an Underrated Financial Stock Investment Play?Brighthouse Financial sells life insurance, but that's not the big story driving the stock right now.
Feb 18, 2026 by Eric VolkmanWhy Tactile Systems Technology Stock Surged by Nearly 18% TodayInvestors were wowed by both the company's trailing performance and its 2026 guidance.
Feb 18, 2026 by Motley Fool YouTubeT-Mobile US: A Strong Contender in the Telecom ArenaCurious about T-Mobile US's stock potential? Join us as we break down its strengths, weaknesses, and what the future might hold for this telecom giant.
Feb 18, 2026 by Eric VolkmanWhy Riot Platforms Stock Zoomed Higher TodayOne of the company's more influential shareholders is concerned about the effects of a strategic transformation on its share price.
Feb 18, 2026 by Keithen DruryDown Nearly 40% From Its All-Time High, Is Netflix Stock Too Cheap to Ignore?Netflix is now valued at the same level as its big tech peers.
Feb 18, 2026 by Eric VolkmanWhy Ferroglobe Stock Was a Winner on WednesdayIt isn't easy to cope with alleged dumping on a company's key markets.
Feb 18, 2026 by Daniel Sparks1 Reason Why Tesla Stock May Keep UnderperformingThe growth stock has struggled this year despite positive updates from CEO Elon Musk.
Feb 18, 2026 by Adria Cimino3 Once-in-a-Decade Buying OpportunitiesBargain-hunters should give these stocks a close look.
Feb 18, 2026 by Reuben Gregg BrewerAGNC Investment Stock Is Interesting, but Here's What I'd Buy InsteadAGNC Investment has a huge 12.6% dividend yield, but it comes with significant risk.
Feb 18, 2026 by Eric VolkmanWhy Global Payments Stock Blasted Nearly 17% Higher on WednesdayThe company believes it will boost its bottom line at a double-digit rate in 2026.
Feb 18, 2026 by Keith NoonanWhy Palo Alto Networks Stock Sank TodayThe cybersecurity specialist's latest quarterly results were better than expected, but there was a big catch.
Feb 18, 2026 by Bram BerkowitzBeyond the Headlines: Is the Financial Sector Still the Best Value Play in 2026?The sector has broadly performed well in recent months.
Feb 18, 2026 by Catie HoganIs Deere & Co. the Smartest Investment You Can Make Today?Deere is facing large macroeconomic challenges as farming continues to struggle in the U.S., but its pivot into AI and cutting-edge technology could prove enormously beneficial.
Feb 18, 2026 by Josh Kohn-LindquistStock Market Today, Feb. 18: ImmunityBio Soars After EU Approves ANKTIVA for Bladder CancerOn Feb. 18, 2026, investors weighed ImmunityBio’s EU bladder cancer win against its long slide since IPO and fresh legal scrutiny.